Brief: Ionis Pharmaceuticals Announces Dr Richard Geary, Chief Development Officer, To Retire
12/06/2025 14:02
June 12 (Reuters) - Ionis Pharmaceuticals Inc IONS.O: IONIS ANNOUNCES DR. RICHARD GEARY, CHIEF DEVELOPMENT OFFICER, TO RETIRE; DR. HOLLY KORDASIEWICZ TO ASSUME ROLE IN JANUARY 2026 Source text: ID:nBw6t8Fbga Further company coverage: IONS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsAnalysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Brief: Ionis Announces License Agreement With Recordati For Zilganersen In Alexander Disease (Axd) In All Countries Outside The U.S.
Brief: Ionis Pharmaceuticals Says FDA Approved Tryngolza For Severe Hypertriglyceridemia
Brief: FDA Approves Treatment To Reduce Risk Of Acute Pancreatitis In Adults With Severe Hypertriglyceridemia
Brief: Ionis Announces Appointment Of Ludwig Hantson, Ph.D. To Board Of Directors